1,657 results on '"Mentz, Robert J"'
Search Results
2. Embracing an era of targeted combination therapy for heart failure with preserved ejection fraction
3. Carbon emissions and air pollution savings among telehealth visits for cardiology appointments
4. Peripheral artery disease, chronic kidney disease, and recurrent admissions for acute decompensated heart failure: The ARIC study
5. Investigating Potential Gender-Based Differential Item Functioning for Items in the Kansas City Cardiomyopathy Questionnaire (KCCQ) Physical Limitations Domain
6. Effects of Sacubitril/Valsartan vs Valsartan in De Novo vs Acute on Chronic HFpEF and HFmrEF
7. Sacubitril/Valsartan-Related Hypotension in Patients With Heart Failure and Preserved or Mildly Reduced Ejection Fraction
8. Recurrent Hospitalizations and Response to Vericiguat in Heart Failure and Reduced Ejection Fraction
9. Regional variation in cause of death in patients with type 2 diabetes: Insights from EXSCEL
10. Frailty Status Modifies the Efficacy of ICD Therapy for Primary Prevention Among Patients With HF
11. Sodium-glucose cotransporter-2 inhibition for heart failure with preserved ejection fraction and chronic kidney disease with or without type 2 diabetes mellitus: a narrative review
12. Sacubitril/Valsartan in Patients Hospitalized With Decompensated Heart Failure
13. Costs of care and financial hardship among patients with heart failure
14. A Phenomapping Tool and Clinical Score to Identify Low Diuretic Efficiency in Acute Decompensated Heart Failure
15. Improving Guideline-Directed Medical Therapy for Patients With Heart Failure With Reduced Ejection Fraction: A Review of Implementation Strategies
16. The HFSA Advanced Heart Failure and Transplant Cardiology Fellowship Consensus Conference
17. Mineralocorticoid Antagonism in Heart Failure: Established and Emerging Therapeutic Role
18. Association of Sacubitril/Valsartan vs Valsartan With Blood Pressure Changes and Symptomatic Hypotension: the PARAGLIDE-HF Trial
19. Standardized Definitions for Evaluation of Acute Decompensated Heart Failure Therapies: HF-ARC Expert Panel Paper
20. Torsemide Versus Furosemide After Discharge in Patients Hospitalized With Heart Failure Across the Spectrum of Ejection Fraction: Findings From TRANSFORM-HF
21. Pharmacotherapies in Heart Failure With Preserved Ejection Fraction: A Systematic Review and Network Meta-Analysis
22. Hierarchical End Points in Prior Heart Failure Trials and the HEART-FID Trial
23. Baseline characteristics of patients in the randomized study to investigate the efficacy and safety of ferric carboxymaltose as treatment for heart failure with iron deficiency: HEART-FID trial
24. Comparative Outcomes of Sacubitril/Valsartan Use After Hospitalization for Heart Failure Among Medicare Beneficiaries Naïve to Renin-Angiotensin System Inhibitors
25. Management of Worsening Heart Failure With Reduced Ejection Fraction: JACC Focus Seminar 3/3
26. High-Intensity Interval Training Versus Moderate Continuous Training in Patients With Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-analysis
27. Abstract 17139: Angiopoietin 2 Independently Predicts Heart Failure Hospitalization and is Beneficially Modified by GLP1RA: Results From the EXSCEL Trial
28. Abstract 16832: Biomarker Enhanced Risk Prediction of Incident Heart Failure in Low-Risk Patients: The Atherosclerosis Risk in Communities (ARIC) Study
29. Abstract 16776: Recurrent Admission of Acute Decompensated Heart Failure Among Patients With and Without PAD and Its Significance in the CKD Population: The ARIC Cohort Study
30. Abstract 16040: Atrial Fibrillation Status and Physical Rehabilitation in Older Patients With Acute Decompensated Heart Failure: An Analysis From the Rehab-HF Trial
31. Abstract 15461: Proteomic Profiling Identifies Metabolic and Extracellular Matrix Markers That Predict MACE in Individuals With Type 2 Diabetes: An EXSCEL Substudy
32. Abstract 14826: Effect of Torsemide vs Furosemide After Discharge for Acute Heart Failure Across the Spectrum of Left Ventricular Ejection Fraction: Observations From Transform-HF
33. Abstract 14756: The Effect of Torsemide vs Furosemide Across the Renal Function Spectrum - Insights From the TRANSFORM-HF Trial
34. Abstract 14698: Effect of Torsemide vs. Furosemide Among Patients With New Onset and Worsening Heart Failure: The Transform-HF Randomized Trial
35. Abstract 14635: Prognostic Value of Heart Rate Variability in Black Americans: The Jackson Heart Study
36. Abstract 12856: Electrocardiographic T Wave Inversion and Cardiac Structure and Function
37. Abstract 12638: The Independent and Joint Associations of Obesity and Hypertension on Incident Heart Failure: A Pooled Cohort Analysis
38. Abstract 12557: Vericiguat Use in a Real-World HFrEF Patient Population: Two Years Post-Launch
39. Palliative Care for Patients With Heart Failure With Preserved Ejection Fraction
40. Angiotensin-Neprilysin Inhibition in Patients With Mildly Reduced or Preserved Ejection Fraction and Worsening Heart Failure
41. Iron Deficiency in Heart Failure: A Scientific Statement from the Heart Failure Society of America
42. The need for increased pragmatism in cardiovascular clinical trials
43. Rationale, Design and Baseline Characteristics of the PARAGLIDE-HF Trial: Sacubitril/Valsartan vs Valsartan in HFmrEF and HFpEF With a Worsening Heart Failure Event
44. Hand Grip Strength Predicts Mortality and Quality of Life in Heart Failure: Insights From the Singapore Cohort of Patients With Advanced Heart Failure
45. Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement From the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society
46. A Roadmap to Reinvigorating Training Pathways Focused on the Care of Patients With Heart Failure: Shifting From Failure to Function
47. Inconsistent Outcome Reporting in Heart Failure Randomized Controlled Trials
48. Practical Patient Care Considerations With Use of Vericiguat After Worsening Heart Failure Events
49. Vitamin D Levels in Black Americans and the Association With Left Ventricular Remodeling and Incident Heart Failure With Preserved Ejectin Fraction: The Jackson Heart Study
50. Do PRO Measures Function the Same Way for all Individuals With Heart Failure?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.